September 1, 2023

Sens. Mag­gie Has­san (D-NH) and Tina Smith (D-MN) are ask­ing the three ma­jor in­sulin man­u­fac­tur­ers — Eli Lil­ly, No­vo Nordisk, and Sanofi — to pro­vide

The FDA on Thurs­day un­veiled its lat­est pro­gram to pro­mote qual­i­ty at drug man­u­fac­tur­ing es­tab­lish­ments, look­ing to push com­pa­nies to go above and be­yond the

Bil­lion­aire Alvotech CEO Róbert Wess­man told in­vestors on Thurs­day that the com­pa­ny has re­sub­mit­ted its Hu­mi­ra in­ter­change­able biosim­i­lar ap­pli­ca­tion to the FDA af­ter re­ceiv­ing a

Cell ther­a­py mak­er Sana Biotech­nol­o­gy is lay­ing off staff, based on about half a dozen em­ploy­ee posts on LinkedIn in re­cent days, say­ing the com­pa­ny

The Stop TB Part­ner­ship an­nounced a 55% de­crease in the price for John­son & John­son’s ver­sion of be­daquiline known as Sir­turo, which is used to

Phar­ma’s rep­u­ta­tion is set­tling in­to a con­sis­tent “new nor­mal,” with now 45% of con­sumers re­port­ing a pos­i­tive per­cep­tion of the in­dus­try, ac­cord­ing to The Har­ris

Mallinck­rodt re­ceived a bit of re­lief in bank­rupt­cy court yes­ter­day af­ter a judge ruled it could ac­cess $150 mil­lion to con­tin­ue to pay em­ploy­ees, ven­dors

Eu­roAPI will ac­quire Ger­man-based BianoGMP, a con­tract man­u­fac­tur­er of oligonu­cleotides, for €10 mil­lion, or $10.9 mil­lion. Found­ed in 2017, BianoGMP main­ly fo­cus­es on pro­duc­ing oligonu­cleotides

Zevra Ther­a­peu­tics is set to buy Ac­er Ther­a­peu­tics in a deal worth up to $91 mil­lion, which finds the Flori­da-head­quar­tered biotech with an ad­di­tion­al two

Ra­di­al Ther­a­peu­tics, a stealth-stage start­up in­side the biotech in­cu­ba­tor Flag­ship Pi­o­neer­ing, is re­fo­cus­ing. “Un­for­tu­nate­ly, we found out re­cent­ly that Ra­di­al has de­cid­ed to stop pur­su­ing